What is the recommended treatment for bacterial conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bacterial Conjunctivitis

For mild bacterial conjunctivitis, prescribe a 5-7 day course of broad-spectrum topical antibiotic applied 4 times daily, which accelerates clinical resolution and reduces transmissibility. 1, 2

Mild Bacterial Conjunctivitis

Treatment approach:

  • Initiate a 5-7 day course of any broad-spectrum topical antibiotic applied 4 times daily 1, 2
  • Choose the most convenient or least expensive option, as no specific antibiotic has proven superiority for uncomplicated cases 2
  • While mild cases are self-limited and may resolve spontaneously, topical antibiotics shorten symptom duration from approximately 4-5 days to 2-3 days and allow earlier return to school or work 1, 3

Effective antibiotic options include:

  • Fluoroquinolones (moxifloxacin, gatifloxacin, ciprofloxacin) - effective against common pathogens including S. aureus, H. influenzae, and S. pneumoniae 1, 4, 5
  • Aminoglycosides (tobramycin, gentamicin) - effective against many common bacterial pathogens 1, 4
  • Azithromycin - dosed twice daily for 2 days, then once daily for 5 days 6
  • Polymyxin B/trimethoprim - alternative option 1
  • Povidone-iodine 1.25% ophthalmic solution - may be as effective as antibiotics when access is limited 1, 2

Key clinical features suggesting bacterial (not viral) conjunctivitis:

  • Mattering and adherence of eyelids on waking 7
  • Purulent discharge 8, 4
  • Lack of itching 7
  • No history of recurrent conjunctivitis 7

Moderate to Severe Bacterial Conjunctivitis

Characterized by copious purulent discharge, pain, and marked inflammation 8, 2

Management approach:

  • Obtain conjunctival cultures and Gram staining before initiating treatment 8, 1
  • Guide antibiotic choice based on laboratory results 8
  • Consider MRSA, which shows increasing prevalence and resistance to many topical antibiotics - may require compounded vancomycin 8, 1, 2

Special Situations Requiring Systemic Therapy

Gonococcal Conjunctivitis

Requires systemic antibiotics - topical therapy alone is insufficient 8, 1, 4

  • Obtain cultures and Gram staining immediately 8
  • Initiate systemic therapy before culture results if high clinical suspicion 8
  • Add saline lavage for comfort and faster resolution 8, 1
  • Treat topically as for bacterial keratitis if corneal involvement present 8
  • Follow daily until resolution with interval history, visual acuity, and slit-lamp examination 8
  • Rule out N. meningitidis before concluding N. gonorrhoeae is responsible 8
  • Evaluate and treat sexual contacts; consider sexual abuse in children 8, 4

Chlamydial Conjunctivitis

Requires systemic antibiotics - topical therapy provides no additional benefit 8, 1, 4

  • Systemic therapy is mandatory in infants, as >50% have infection at other sites (nasopharynx, genital tract, lungs) 8
  • Treatment failure occurs in up to 19% of cases - re-evaluate following treatment 8
  • Evaluate and treat sexual contacts; consider sexual abuse in children 8, 4

Follow-Up and Referral

Advise patients to return in 3-4 days if no improvement 8, 1, 4

Refer to ophthalmology for:

  • Visual loss 1, 4
  • Moderate or severe pain 1, 4
  • Severe purulent discharge 1, 4
  • Corneal involvement 1, 4
  • Conjunctival scarring 1, 4
  • Lack of response to therapy 1, 4
  • Recurrent episodes 1, 4

Critical Pitfalls to Avoid

  • Do not use topical corticosteroids unless under ophthalmology supervision, as they may prolong bacterial shedding and worsen infection 4
  • Increasing MRSA resistance is a growing concern - consider culture-guided therapy for treatment failures 8, 1, 9
  • Poor adherence to frequent dosing regimens contributes to treatment failure and resistance 1, 9
  • Always consider gonococcal or chlamydial infection in neonates and sexually active patients, as these require systemic therapy 8, 1
  • Screen for sexual abuse in children with gonococcal or chlamydial conjunctivitis 8, 4, 2

References

Guideline

Treatment of Bacterial Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Bacterial Conjunctivitis: Frequency and Duration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Infectious Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Limitations of current antibiotics for the treatment of bacterial conjunctivitis.

Optometry and vision science : official publication of the American Academy of Optometry, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.